G. Fumagalli

发表

MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases

Nick C Fox, P. Scheltens, F. Barkhof, 2016, Brain : a journal of neurology.

Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study

Veronica Redaelli, Sebastien Ourselin, Martina Bocchetta, 2019, Brain : a journal of neurology.

MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2020, Cells.

Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, The Lancet Neurology.

PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.

D. Mari, S. Sorbi, C. Mariani, 2016, Journal of Alzheimer's disease : JAD.

Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis.

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Multiple sclerosis and related disorders.

Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes

M. Bozzali, D. Galimberti, C. Fenoglio, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia

N. Bresolin, S. Cappa, D. Galimberti, 2011, Alzheimer's & Dementia.

Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations

D. Galimberti, C. Fenoglio, E. Scarpini, 2015, International journal of molecular sciences.

Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred.

N. Bresolin, D. Galimberti, C. Fenoglio, 2011, Journal of Alzheimer's disease : JAD.

Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration?

N. Bresolin, S. Cappa, M. Franceschi, 2010, Neuroscience Letters.

White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, NeuroImage: Clinical.

Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem)

D. Perani, C. Babiloni, M. Bozzali, 2022, Neurological Sciences.

Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study

D. Galimberti, M. Bocchetta, J. Rohrer, 2018, Neurobiology of Aging.

Diagnosis of Frontotemporal Dementia

G. Fumagalli, 2018 .

CSF β-amyloid and white matter damage: a new perspective on Alzheimer’s disease

Giovanni Giulietti, Marco Bozzali, Alberto Calvi, 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

Inflammatory molecules in Frontotemporal Dementia: Cerebrospinal fluid signature of progranulin mutation carriers

D. Galimberti, C. Fenoglio, E. Scarpini, 2015, Brain, Behavior, and Immunity.

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Nick C Fox, Jennifer M. Nicholas, J. Morris, 2019, The Lancet Neurology.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

Kevin F. Bieniek, C. Geula, M. Mesulam, 2018, The Lancet Neurology.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal dementia and GRN mutations: a genome-wide association study

Elizabeth, Sandro, Ying-xue, 2018 .

Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation

F. Turkheimer, D. Galimberti, C. Fenoglio, 2022, Alzheimer's Research & Therapy.

miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia

D. Galimberti, C. Fenoglio, M. Serpente, 2022, International journal of molecular sciences.

Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations.

N. Bresolin, D. Galimberti, C. Fenoglio, 2012, Journal of Alzheimer's disease : JAD.

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2022, Journal of Neuroinflammation.

The search for a link between autism spectrum disorder and neurodegenerative dementia

A. Crippa, G. Fumagalli, 2022, Minerva Psychiatry.

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Jennifer M. Nicholas, P. Thompson, R. Keren, 2022, Journal of Neurology.

The CBI‐R detects early behavioural impairment in genetic frontotemporal dementia

Nick C Fox, M. Freedman, S. Ourselin, 2022, Annals of clinical and translational neurology.

Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation

D. Galimberti, C. Fenoglio, E. Scarpini, 2017, Neurology.

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Jennifer M. Nicholas, Sheng-Yang M. Goh, M. Freedman, 2022, Nature Medicine.

Monozygotic Twins with Frontotemporal Dementia Due To Thr272fs GRN Mutation Discordant for Age At Onset.

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Journal of Alzheimer's disease : JAD.

Diogenes syndrome in dementia: a case report

P. Brambilla, D. Galimberti, E. Scarpini, 2021, BJPsych Open.

Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy.

G. Comi, D. Galimberti, E. Scarpini, 2014, Immunotherapy.

A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation

N. Bresolin, D. Galimberti, E. Scarpini, 2012, Neurology.

Diencephalic versus Hippocampal Amnesia in Alzheimer’s Disease: The Possible Confabulation-Misidentification Phenotype

P. Nicolini, P. Trimarchi, B. Arosio, 2022, Journal of Alzheimer's disease : JAD.

A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2022, Biomedicines.

Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis

A. Bianchi, D. Galimberti, C. Fenoglio, 2022, European Radiology.

GENFI - The GENetic Frontotemporal dementia Initiative

M. Freedman, R. Keren, G. Frisoni, 2012 .

CSF β-amyloid predicts prognosis in patients with multiple sclerosis

M. Bozzali, D. Galimberti, C. Fenoglio, 2018, Multiple sclerosis.

Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy

N. Bresolin, M. Bozzali, D. Galimberti, 2015, PloS one.

Behavioral and Neurophysiological Effects of Transcranial Direct Current Stimulation (tDCS) in Fronto-Temporal Dementia

A. Priori, S. Marceglia, M. Vergari, 2018, Front. Behav. Neurosci..

Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect

Arosio, D. Galimberti, C. Fenoglio, 2023, GeroScience.

Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study

D. Galimberti, C. Fenoglio, E. Scarpini, 2020, Neurological Sciences.

Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study

Jennifer M. Nicholas, M. Freedman, N. Fox, 2021, Alzheimer's & dementia.

Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2020, Cortex.

Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes

N. Bresolin, D. Galimberti, C. Fenoglio, 2010, Neuroscience Letters.

Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration.

N. Bresolin, S. Cappa, M. Franceschi, 2011, Rejuvenation research.

A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2021, Brain : a journal of neurology.

Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis

Veronica Redaelli, Sebastien Ourselin, Martina Bocchetta, 2015, The Lancet Neurology.

Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2019, Neurobiology of Aging.

BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease.

N. Bresolin, S. Cappa, M. Franceschi, 2011, Journal of Alzheimer's disease : JAD.

Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales

Nick C Fox, M. Freedman, S. Ourselin, 2018, Alzheimer's research & therapy.

Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

Jennifer M. Nicholas, M. Freedman, R. Keren, 2022, Journal of Neurology.

Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

M. Freedman, J. Dukart, R. Keren, 2023, Neurobiology of Disease.

Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation

G. Comi, S. Cappa, M. Filippi, 2013, Biological Psychiatry.

Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia

B. Nacmias, D. Galimberti, M. Bocchetta, 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2020, NeuroImage: Clinical.

Alzheimer’s Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study

D. Mari, E. Scarpini, M. Marcucci, 2017, Front. Med..

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2017, Nature Communications.

Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease

D. Galimberti, E. Scarpini, F. Triulzi, 2020, NeuroImage: Clinical.

Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters

D. Galimberti, E. Scarpini, M. D. De Riz, 2021, Neurological Sciences.

Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort

J. E. Iglesias, Jennifer M. Nicholas, M. Freedman, 2023, Brain communications.

Differential early subcortical involvement in genetic FTD within the GENFI cohort

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2021, NeuroImage: Clinical.

Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males

N. Bresolin, G. Comi, D. Galimberti, 2010, Genes and Immunity.

Crossing Borders Between Frontotemporal Dementia and Psychiatric Disorders: An Updated Overview.

B. Dell’Osso, L. Cremaschi, G. Fumagalli, 2020, Journal of Alzheimer's disease : JAD.

The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients

Francesco Viola, Eleonora Benatti, Fabio Triulzi, 2019, Multiple sclerosis.

Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer’s disease

N. Bresolin, F. Clerici, C. Mariani, 2011, Journal of Neurology.

Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia.

P. Mazzanti, C. Mussi, D. Cucinotta, 2020, Journal of the American Medical Directors Association.

Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Journal of Alzheimer's disease : JAD.

Circulating miRNAs as potential biomarkers in Alzheimer's disease.

D. Galimberti, C. Fenoglio, E. Scarpini, 2014, Journal of Alzheimer's disease : JAD.

Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study.

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, Journal of Alzheimer's disease : JAD.

Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu‐Hakola Disease

D. Galimberti, C. Fenoglio, L. Piccio, 2019, Cytokine.

Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+?

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Journal of Alzheimer's disease : JAD.

Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Alzheimer's Research & Therapy.

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis

M. Bozzali, D. Galimberti, C. Fenoglio, 2017, Multiple sclerosis.

Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression

D. Galimberti, E. Scarpini, M. D. De Riz, 2020, Multiple sclerosis.

Language impairment in the genetic forms of behavioural variant frontotemporal dementia

Jennifer M. Nicholas, M. Freedman, R. Keren, 2022, Journal of Neurology.

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

Jennifer M. Nicholas, M. Freedman, S. Ourselin, 2021, Molecular Neurodegeneration.

Sciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathy

N. Bresolin, D. Galimberti, E. Scarpini, 2012, Journal of Neurology.

Theme 08 - Clinical Imaging and Electrophysiology

Jennifer M. Nicholas, M. Freedman, R. Keren, 2022, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia.

A. Leemans, A. Bianchi, D. Galimberti, 2021, Journal of Alzheimer's disease : JAD.

Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience.

D. Galimberti, E. Scarpini, A. Nobili, 2021, Journal of Alzheimer's disease : JAD.

Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.

D. Galimberti, C. Fenoglio, E. Scarpini, 2021, Journal of Alzheimer's disease : JAD.

Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome.

D. Galimberti, C. Fenoglio, E. Scarpini, 2020, Journal of Alzheimer's disease : JAD.

Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.

D. Galimberti, C. Fenoglio, E. Scarpini, 2018, Journal of Alzheimer's disease : JAD.

Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage

M. Bozzali, D. Galimberti, C. Fenoglio, 2022, Alzheimer's research & therapy.

Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there?

N. Bresolin, S. Corti, D. Galimberti, 2021, Internal and Emergency Medicine.

Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Journal of Alzheimer's disease : JAD.

Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

Nick C Fox, Jennifer M. Nicholas, M. Freedman, 2022, Journal of Neuroinflammation.

Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes

D. Galimberti, C. Fenoglio, E. Scarpini, 2019, Alzheimer's Research & Therapy.

Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

Jennifer M. Nicholas, M. Freedman, R. Keren, 2023, Journal of the Neurological Sciences.

Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status

D. Galimberti, C. Fenoglio, E. Scarpini, 2023, European journal of neurology.

Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation

M. Filippi, M. Franceschi, F. Agosta, 2013, Biological Psychiatry.

Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred.

N. Bresolin, D. Galimberti, C. Fenoglio, 2011, Journal of Alzheimer's disease : JAD.

Circulating miRNAs as potential biomarkers in Alzheimer’s disease

D. Galimberti, C. Fenoglio, E. Scarpini, 2013 .

Telemedicine for cognitive impairment: a telephone survey of patients’ experiences with neurological video consultation

S. Barbieri, R. Ferrucci, E. Scarpini, 2023, Neurological Sciences.

Diagnostic accuracy of research criteria for prodromal frontotemporal dementia

Y. Pijnenburg, T. Rittman, B. Nacmias, 2024, Alzheimer's Research & Therapy.

Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia.

P. Mazzanti, C. Mussi, D. Cucinotta, 2020, Journal of the American Medical Directors Association.

Altered plasma protein profiles in genetic FTD – a GENFI study

S. Ourselin, H. Karnath, Y. Pijnenburg, 2023, Molecular Neurodegeneration.

Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

A. Danek, Y. Pijnenburg, R. Vandenberghe, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Analysis of brain atrophy and local gene expression implicates astrocytes in Frontotemporal dementia

C. Fenoglio, E. Scarpini, R. Bruffaerts, 2019 .

Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis

J. Graff‐Radford, M. Murray, Y. Pijnenburg, 2024, The Lancet Neurology.

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

S. Ourselin, R. Keren, H. Karnath, 2021, Molecular Neurodegeneration.